While it may seem like cosmetic procedures such as fillers and Botox are uncommon, their popularity continues to rise. In fact, in the year 2015 alone, Americans were injected more than 6.6 million times. According to the American Society for Aesthetic Plastic Surgery, this number is a 40 percent increase from only five years ago, showing just how popular these types of treatments have become.
Allergen, the pharmaceutical company behind Botox, has just announced some exciting news for those 6 million and counting patients: its newest filler, Juvederm Vollure™, has been granted FDA approval.
